BEAM THERAPEUTICS INC (BEAM) Stock Earnings & Estimates
USA - NASDAQ:BEAM - US07373V1052 - Common Stock
22.295 USD
+0.43 (+1.94%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 60.92M 17.52% | 377.709M 520.01% | 63.518M -83.18% | 42.746M -32.70% | 50.872M 19.01% | 60.533M 18.99% | 137.71M 127.50% | 458.21M 232.74% | 888.88M 93.99% | 1.009B 13.51% | 1.467B 45.39% | |
| EBITDA YoY % growth | -324.33M 15.76% | -156.473M 51.76% | -393.643M -151.57% | -465.205M -18.18% | -486.28M -4.53% | -528.026M -8.58% | -249.798M 52.69% | -207.57M 16.90% | -137.7M 33.66% | N/A | N/A | |
| EBIT YoY % growth | -338.48M 13.76% | -176.485M 47.86% | -415.568M -135.47% | -487.553M -17.32% | -524.826M -7.64% | -565.708M -7.79% | -553.316M 2.19% | -390.752M 29.38% | -108.571M 72.21% | 1.917M 101.77% | 201.31M 10,401.30% | |
| Operating Margin | -555.61% | -46.73% | -654.25% | -1,140.58% | -1,031.66% | -934.54% | -401.80% | -85.28% | -12.21% | 0.19% | 13.72% | |
| EPS YoY % growth | -4.13 30.47% | -1.90 54.00% | -4.58 -141.05% | -4.42 3.42% | -4.51 -2.00% | -4.74 -5.03% | -3.79 20.06% | -2.62 30.90% | -1.29 50.91% | 0.85 166.03% | 3.30 288.52% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.16 -6.57% | -1.20 3.14% | -1.12 -12.40% | -1.18 -7.56% | -1.18 -1.86% | -1.85 -53.88% | -1.95 -73.50% | -1.90 -60.69% | -1.83 -54.57% |
| Revenue Q2Q % growth | 13.433M -55.32% | 15.93M 113.25% | 17.328M 104.68% | 17.498M 80.43% | 17.668M 31.53% | 8.635M -45.79% | 8.635M -50.17% | 8.635M -50.65% | 20.212M 14.40% |
| EBITDA Q2Q % growth | -116.859M -49.60% | -135.71M -19.30% | -86.598M 20.61% | -87.312M 20.76% | -88.23M 24.50% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -115.693M -15.65% | -133.594M -11.99% | -110.415M 8.10% | -114.342M 9.83% | -115.821M -0.11% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -1.10 5.98% | -1.06 | -0.04 | -3.72% |
| Q2 2025 Q2Q % growth | -1.00 9.91% | -1.13 | 0.13 | 11.65% |
| Q1 2025 Q2Q % growth | -1.24 -2.48% | -1.23 | -0.01 | -0.76% |
| Q4 2024 Q2Q % growth | -1.09 -163.01% | -1.23 | 0.14 | 11.25% |
| Q3 2024 Q2Q % growth | -1.17 4.10% | -1.18 | 0.01 | 0.76% |
| Q2 2024 Q2Q % growth | -1.11 -2.78% | -1.15 | 0.04 | 3.51% |
| Q1 2024 Q2Q % growth | -1.21 9.02% | -1.45 | 0.24 | 16.31% |
| Q4 2023 Q2Q % growth | 1.73 420.37% | -1.03 | 2.76 | 267.72% |
| Q3 2023 Q2Q % growth | -1.22 21.79% | -1.39 | 0.17 | 12.16% |
| Q2 2023 Q2Q % growth | -1.08 -5.88% | -1.45 | 0.37 | 25.68% |
| Q1 2023 Q2Q % growth | -1.33 -31.68% | -1.37 | 0.04 | 2.85% |
| Q4 2022 Q2Q % growth | -0.54 43.16% | -1.35 | 0.81 | 60.13% |
| Q3 2022 Q2Q % growth | -1.56 -271.43% | -1.34 | -0.22 | -16.50% |
| Q2 2022 Q2Q % growth | -1.02 17.07% | -1.10 | 0.08 | 7.25% |
| Q1 2022 Q2Q % growth | -1.01 69.76% | -1.35 | 0.34 | 24.99% |
| Q4 2021 Q2Q % growth | -0.95 43.79% | -1.05 | 0.10 | 9.38% |
| Q3 2021 Q2Q % growth | -0.42 39.13% | -0.75 | 0.33 | 44.10% |
| Q2 2021 Q2Q % growth | -1.23 -78.26% | -0.66 | -0.57 | -86.60% |
| Q1 2021 Q2Q % growth | -3.34 -224.27% | -0.75 | -2.59 | -343.25% |
| Q4 2020 Q2Q % growth | -1.69 62.19% | -0.68 | -1.01 | -146.77% |
| Q3 2020 Q2Q % growth | -0.69 | -0.57 | -0.12 | -21.67% |
| Q2 2020 Q2Q % growth | -0.69 | -0.54 | -0.15 | -28.12% |
| Q1 2020 Q2Q % growth | -1.03 | -0.52 | -0.51 | -99.96% |
| Q4 2019 Q2Q % growth | -4.47 | -0.53 | -3.94 | -737.40% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 9.698M -32.03% | 12.662M | -2.964M | -23.41% |
| Q2 2025 Q2Q % growth | 8.466M -28.08% | 13.836M | -5.37M | -38.81% |
| Q1 2025 Q2Q % growth | 7.47M 0.81% | 15.164M | -7.694M | -50.74% |
| Q4 2024 Q2Q % growth | 30.067M -90.49% | 17.269M | 12.798M | 74.11% |
| Q3 2024 Q2Q % growth | 14.269M -17.01% | 14.789M | -520K | -3.52% |
| Q2 2024 Q2Q % growth | 11.772M -41.48% | 14.466M | -2.694M | -18.62% |
| Q1 2024 Q2Q % growth | 7.41M -69.39% | 17.307M | -9.897M | -57.18% |
| Q4 2023 Q2Q % growth | 316.192M 1,477.80% | 19.046M | 297.146M | 1,560.15% |
| Q3 2023 Q2Q % growth | 17.193M 8.82% | 17.458M | -265K | -1.52% |
| Q2 2023 Q2Q % growth | 20.116M 20.82% | 18.413M | 1.703M | 9.25% |
| Q1 2023 Q2Q % growth | 24.208M 187.16% | 14.359M | 9.849M | 68.59% |
| Q4 2022 Q2Q % growth | 20.04M -60.76% | 12.989M | 7.051M | 54.28% |
| Q3 2022 Q2Q % growth | 15.8M 1,978.95% | 7.294M | 8.506M | 116.62% |
| Q2 2022 Q2Q % growth | 16.65M 166,400.00% | 8.558M | 8.092M | 94.55% |
| Q1 2022 Q2Q % growth | 8.43M 84,200.00% | 6.024M | 2.406M | 39.94% |
| Q4 2021 Q2Q % growth | 51.07M 510,600.00% | 2.36M | 48.71M | 2,063.98% |
| Q3 2021 Q2Q % growth | 760K 7,500.00% | 7.335M | -6.575M | -89.64% |
| Q2 2021 Q2Q % growth | 10K | 2.04K | 7.96K | 390.20% |
| Q1 2021 Q2Q % growth | 10K | 1.744K | 8.256K | 473.33% |
| Q4 2020 Q2Q % growth | 10K | 2.04K | 7.96K | 390.20% |
| Q3 2020 Q2Q % growth | 10K | 1.53K | 8.47K | 553.59% |
| Q2 2020 Q2Q % growth | 10K | 1.53K | 8.47K | 553.59% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.57% | 6.55% | -0.03% | 5.44% |
| Revenue | 0.07% | -16.4% | -0.37% | -19.96% |